Search
-
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.
(Leukemia. vol. 35, n° 4, pp. 935-955, 2021-01-01)Article de revue -
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
(Blood. vol. 140, n° Supplement 1, pp. 9668-9669, 2022-11-15)Article de revue -
Circulating endothelial cells in pathophysiology.
(Current Opinion in Hematology. vol. 31, n° 3, pp. 148-154, 2024-05-01)Article de revue -
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
(Haematologica, 2024-02-08)Article de revueOpen access -
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueOpen access